“Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma” (2026) Journal of Cancer Research Updates, 15(3), pp. 197–205. doi:10.30683/1929-2279.2026.15.18.